Business
HEALWELL AI Announces Strategic Investment and Commercialization Agreement with Abstractive Health to Advance Generative AI-Powered Clinical Documentation Solutions
HEALWELL AI completes a strategic investment in NY-based Abstractive Health, alongside lead inves...
About this update from Healwell Ai Inc. Class A
[{"type":"text","content":"HEALWELL AI Announces Strategic Investment and Commercialization Agreement with Abstractive Health to Advance Generative AI-Powered Clinical Documentation SolutionsHEALWELL AI completes a strategic investment in NY-based Abstractive Health, alongside lead investor Rho Capital Partners, to support the development of AI-driven clinical documentation technology.Concurrent with the investment, HEALWELL also entered into a commercial agreement with Abstractive Health that provides HEALWELL with exclusive distribution rights to the Canadian outpatient healthcare market.Abstractive Health's AI software leverages LLMs and other generative AI technology to automate medical record summaries for physicians and clinicians, streamlining healthcare documentation processes.HEALWELL expects to leverage its strategic relationship with WELL Health Technologies (TSX: WELL) and add Abstractive Health to WELL's apps.health marketplace and grow its cadre of co-pilot technologies to further tech enable healthcare providers. Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (\"HEALWELL\" or the \"Company\"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce its USD$250,000 strategic investment in Abstractive Health (\"Abstractive Health\"), a healthcare AI company specializing in providing physicians with an automated, accurate and medically relevant AI assistant that delivers patient summaries using proprietary generative AI technology. This investment is part of a broader funding round, led by Rho Capital Partners as lead investor and Cornell University via Cornell Technology as an existing investor. Leveraging the current Conditional Decision Support co-pilots HEALWELL currently offers, the Company will have the exclusive right to distribute Abstractive's products as an extension of its existing AI-enabled co-pilot technology suite through WELL Health Technologies' extensive network of outpatient healthcare clinics.Founded in 2022 and based in New York, Abstractive Health is a pioneer in healthcare AI led by co-founder and CEO Vince Hartman. Abstractive Health is transforming the healthcare industry by automating the summarization of patient medical records through its AI-powered software, designed to assist physicians and clinicians in reduc...